Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

CENTRAL PENNSYLVANIA BLOOD BANK

UEI: GE17LEU396S3CAGE: 3UBR6

CENTRAL PENNSYLVANIA BLOOD BANK is a federal contractor, registered under UEI GE17LEU396S3 and CAGE code 3UBR6. It has been awarded $3,557,767 in federal contracts. Primary work spans Blood and Organ Banks and Unknown NAICS. Top awarding agencies include Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

GE17LEU396S3

CAGE Code

3UBR6

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Non-Profit Organization

NAICS Codes

621991Blood and Organ Banks(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Central Pennsylvania Blood Bank specializes in the collection, processing, storage, and distribution of blood and blood products to support critical healthcare needs within federal medical facilities. Their core capabilities center on donor recruitment, plasma fractionation, pathogen reduction techn...

Central Pennsylvania Blood Bank specializes in the collection, processing, storage, and distribution of blood and blood products to support critical healthcare needs within federal medical facilities. Their core capabilities center on donor recruitment, plasma fractionation, pathogen reduction technologies, and cold chain logistics for blood components including red cells, platelets, and plasma derivatives. The contractor ensures strict adherence to AABB standards and FDA regulations, delivering clinically validated, traceable blood products with full chain-of-custody documentation. Their technical expertise includes automated blood banking systems, nucleic acid testing for infectious agents, and inventory management protocols compliant with Joint Commission and CAP requirements. A key differentiator is their ability to maintain just-in-time delivery of time-sensitive blood products to remote or high-demand clinical settings, ensuring operational continuity for trauma and surgical services. The contractor maintains a consistent, long-standing relationship with the Department of Veterans Affairs, providing blood products and associated services specifically to the Lebanon VA Medical Center. Their work supports VA’s mission-critical transfusion services, ensuring veteran patients receive safe, timely, and appropriately matched blood components for chronic conditions, surgeries, and emergency care. This recurring engagement reflects deep integration into VA’s transfusion medicine infrastructure and a proven ability to meet stringent federal healthcare delivery standards. The primary NAICS code 621991 reflects their exclusive focus on blood and organ banking operations, positioning them as a specialized provider within the federal medical supply chain. They operate in a highly regulated vertical requiring compliance with biosafety, donor screening, and product labeling mandates, distinguishing them from general medical suppliers. As a small business entity structured under 8H, Central Pennsylvania Blood Bank operates from Hummelstown, Pennsylvania, serving federal healthcare markets with localized logistics efficiency. While no formal government certifications are listed, their consistent performance under federal contracts demonstrates operational reliability and adherence to federal quality benchmarks in transfusion medicine.

Key Performance Metrics

Awards Count

37

All time

Active

1

Currently performing

Completed

36

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
621991 - Blood and Organ Banks$3.4M95.6%
- Unknown NAICS$155.2K4.4%
Awards by Agency Over Time
Awards by Place of Performance

Compete with CENTRAL PENNSYLVANIA BLOOD BANK

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for CENTRAL PENNSYLVANIA BLOOD BANK

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in CENTRAL PENNSYLVANIA BLOOD BANK's top NAICS codes and agencies

NAICS: 621991
New
Federal
Human Cadaver - Based Medical Training and Program Support Services for the 44th Medical Brigade stationed at Fort Bragg Army Base, North Carolina.
Solicitation # 0012468284
The Medical Acquisition Support Office – Alpha is seeking capable vendors to provide human cadaver-based medical training and program support for the 44th Medical Brigade. The scope of work includes the procurement and delivery of up to 20 ethically sourced, non-dissected perfused whole-body cadaver specimens annually, which must be serologically negative for HIV, Hepatitis B/C, and Syphilis. The contractor is responsible for providing refrigerated transportation to primary performance sites at Fort Bragg, NC; Fort Campbell, KY; Fort Stewart-Hunter Army Airfield, GA; and Fort Polk, LA. Additionally, the contractor must provide rental medical equipment and consumable Class VIII supplies, such as surgical packs, tourniquets, and simulated blood. The requirement includes providing highly qualified Subject Matter Experts (SMEs) to support up to 10 training events per fiscal year. These SMEs must be board-certified general surgeons with specific competencies in various trauma procedures, such as cricothyroidotomy and exploratory laparotomy, to serve as instructors and mentors. The anticipated contract structure consists of a base period followed by four one-year option periods. All personnel must comply with strict Installation Access Control System requirements, including Anti-Terrorism Level I and iWatch training, to gain access to military installations.
W40M MRC0 West

POSTED

2 days ago

DEADLINE

in 9 days
View Details
NAICS: 561990
New
Federal
Intent to Sole Source Fire Suppression and Emergency Response Service
Solicitation # 36C26326Q0635_1
The Department of Veterans Affairs, Network Contracting Office 23, intends to award a sole source contract to the City of Minneapolis for fire suppression and emergency response services at the Veterans Affairs Medical Center in Minneapolis, Minnesota, including buildings at Fort Snelling. This action is being taken under the authority of FAR 6.103-1 and FAR 12.102(a), as the government has determined that only one responsible source can satisfy the agency requirements. The contractor is required to provide 24/7 contractor owned and contractor operated services, including responses to fire alarms, hazardous material spills, confined space rescues, and elevator entrapments. Key performance requirements include maintaining a minimum of four certified professional firefighters and two fire pumper apparatus with at least 1200 gpm capacity, ensuring a maximum response time of eight minutes to any location on the campus. The contractor must adhere to NFPA, IFC, OSHA, and State of Minnesota standards, maintain a minimum ISO rating of 3, and hold mutual aid agreements with at least two other municipal fire departments. Deliverables include annual building inspections, a phase-in plan due within ten days of award, and a confined space rescue plan due within fourteen days of the notice of award. Interested parties wishing to challenge the sole source determination must submit a capabilities statement by October 23, 2026.
Department Of Veterans Affairs

POSTED

6 days ago

DEADLINE

in 2 days
View Details
NAICS: 621991
New
Federal
6505--Human Blood and Blood Products
Solicitation # 36C25727Q0049
The Department of Veterans Affairs, Network Contracting Office 17, intends to award a single-award, firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the South Texas Blood and Tissue Center. This procurement is for the supply and delivery of human blood and blood products, as well as guidance in clinical pathology procedures, to support the Audie L. Murphy Veterans Health Care Center within the South Texas Veterans Health Care System in San Antonio, Texas. The government is pursuing this as a sole source procurement under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.103-1, asserting that only one responsible source can satisfy the agency's requirements. The contractor must maintain AABB and College of American Pathologists (CAP) accreditation and hold an unrevoked U.S. license from the FDA Bureau of Biologics. Key operational requirements include 24/7/365 availability and a tiered delivery system: STAT orders must be delivered within 60 minutes, ASAP orders within 2 hours, and routine orders within 24 hours. All products must be collected via closed systems under aseptic conditions, labeled according to the ABO Blood Group System and Rh type, and transported in compliance with FDA, AABB, and DOT regulations to ensure proper temperature maintenance. Acceptance of deliveries is based on STVHCS Blood Bank criteria, including physical appearance, contamination checks, and specific shelf-life minimums for red blood cells, plasma, and cryoprecipitate.
257-NETWORK Contract Office 17 (36C257)

POSTED

6 days ago

DEADLINE

in 15 days
View Details
NAICS: 621991
New
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute (NCI) has issued a Limited Competition Notice of Funding Opportunity (RFA-CA-28-004) to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain these national resources for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens. These resources facilitate translational cancer research, biomarker development, and validation by providing essential specimens from NCI-funded clinical trials. The NCI intends to fund approximately six awards for fiscal year 2027, with a total estimated funding of 19 million dollars and a maximum budget of 3 million dollars in direct costs per year for a requested project period of six years. Applications will be evaluated through the NIH peer-review system based on scientific and technical merit, significance, and the adequacy of the institutional environment. Key requirements for applicants include maintaining active registrations in SAM, eRA Commons, and Grants.gov, as well as providing specific documentation regarding the current scale of operations, accomplishments, and standard operating procedures. Awardees must adhere to NCI Best Practices for Biospecimen Resources, federal human subjects regulations under 45 CFR 46, and strict cybersecurity incident reporting protocols, including notification of incidents within 48 hours of discovery. The scope of work includes managing secure informatics systems, providing specimen collection kits, and ensuring the availability of annotated biospecimens for authorized investigators.
National Institutes Of Health

POSTED

6 days ago

DEADLINE

in 4 months
View Details
NAICS: 621991
New
Grant
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Solicitation # RFA-CA-28-004
The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.
National Cancer Institute

POSTED

6 days ago

DEADLINE

in 4 months
View Details